Trial intelligence / Profile preview

Metformin for Insulin Resistance in Chronic Hepatitis C Genotype 1

NCT00546442Phase 4Completed

Sponsor
Hospital Universitario Virgen de Valme
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in hepatitis C (HCV) comparing Metformin with Placebo (2 arms). Primary endpoint: Percentage of patients with HCV-RNA negative at Week 72. Started May 2006; status: completed.

02

Drugs

metformin
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00546442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00546442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call